MARSHALL & POPP, LLC for BUTTERFLY NETWORK, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act, and H.R.2617, Consolidated Appropriations Act, 2023. Issues related to FDA regulation of medical devices, including including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R.6833, Making continuing appropriations for fiscal year 2023, and H.R.2617, Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles |
| MONICA POPP | Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint |
Medical/Disease Research/Clinical Labs MED
Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act, and H.R.2617, Consolidated Appropriations Act, 2023. Issues related to FDA regulation of medical devices, including including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R.6833, Making continuing appropriations for fiscal year 2023, and H.R.2617, Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Pharmacy PHA
Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act, and H.R.2617, Consolidated Appropriations Act, 2023. Issues related to FDA regulation of medical devices, including including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R.6833, Making continuing appropriations for fiscal year 2023, and H.R.2617, Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Science/Technology SCI
Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act, and H.R.2617, Consolidated Appropriations Act, 2023. Issues related to FDA regulation of medical devices, including including S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, H.R.6833, Making continuing appropriations for fiscal year 2023, and H.R.2617, Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.